Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial to Determine the Most Appropriate Time to Start HIV Treatment in HIV & TB Coinfected Adults Being Treated for Tuberculosis.

NCT01315301 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT01315301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01315301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial to Determine the Most Appropriate Time to Start HIV Treatment in HIV & TB Coinfected Adults Being Treated for Tuberculosis.
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2008
Completion date
March 31, 2012
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immunodeficiency syndrome, tuberculosis